Männedorf, Switzerland – Tecan’s Cavro® Omni Robot has been incorporated into Applied Photophysics’ new protein discovery solution, the Chirascan™-plus CD Spectrometer. This newly created system combines Tecan’s precise and reliable sample handling with excellent measurement reproducibility, opening up a wide range of circular dichroism (CD) applications for the first time.

The Cavro Omni Robot has enabled Applied Photophysics to automate sample preparation for CD, as Project Leader Lindsay Cole explained: “The Omni Robot is an open and malleable liquid handling component, and was very easy to incorporate into our system. It has eliminated the need to design and integrate our own fluidics, sample probe and injection port, as well as giving us a number of useful features – such as the sample level sensing – and the option to add other sample handling and preparation capabilities in the future.”

“Automation has significantly increased the practical throughput of the Chirascan, allowing unattended running with minimal user intervention and reducing labor requirements per measurement by 90 %. This, combined with the reliability and increased reproducibility offered by the Cavro Omni Robot, has greatly increased the appeal of CD as an analytical technique for proteins, particularly for the biopharmaceuticals development market.”

About Tecan

Tecan (www.tecan.com) is a leading global provider of laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics. The company specializes in the development, production and distribution of instruments and automated workflow solutions for laboratories in the life sciences sector. As an original equipment manufacturer, Tecan is also a leader in developing and manufacturing OEM instruments and components that are then distributed by partner companies. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both Europe and North America and maintains a sales and service network in 52 countries. In 2009, Tecan generated sales of CHF 392 million (USD 361.2 million; EUR 259.6 million). Registered shares of Tecan Group are traded on the SIX Swiss Exchange (TK: TECN/Reuters: TECZn.S/ ISIN CH0012100191).